<code id='B878CC7705'></code><style id='B878CC7705'></style>
    • <acronym id='B878CC7705'></acronym>
      <center id='B878CC7705'><center id='B878CC7705'><tfoot id='B878CC7705'></tfoot></center><abbr id='B878CC7705'><dir id='B878CC7705'><tfoot id='B878CC7705'></tfoot><noframes id='B878CC7705'>

    • <optgroup id='B878CC7705'><strike id='B878CC7705'><sup id='B878CC7705'></sup></strike><code id='B878CC7705'></code></optgroup>
        1. <b id='B878CC7705'><label id='B878CC7705'><select id='B878CC7705'><dt id='B878CC7705'><span id='B878CC7705'></span></dt></select></label></b><u id='B878CC7705'></u>
          <i id='B878CC7705'><strike id='B878CC7705'><tt id='B878CC7705'><pre id='B878CC7705'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:6
          om DiLenge (CQ in grey suit ) Flagship Pioneering Cambridge with US Congressman Raja Krishnamoorthi of Illinois were talking together at the event. Biotech companies demonstrating their medicines and materials at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge. The growing US backlash against the perceived national security threat posed by China's rising biotech industry
          Tom DiLenge of Flagship Pioneering (left) with U.S. Congressman Raja Krishnamoorthi of Illinois at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge, Mass. David L Ryan/The Boston Globe

          CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of the U.S. economy, such as technology, manufacturing, and clean energy.

          Now, some in Congress are raising alarms about China’s threat to another vital industry: biotechnology.

          advertisement

          A bipartisan group of lawmakers visited Massachusetts this week to call attention to that threat and call for strengthening U.S. life sciences companies, protecting their technologies, and safeguarding Americans’ genetic data from a Chinese biotech industry with close ties to the authoritarian state.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Crowdfunding for unproven stem cell procedures spreads misinformation
          Crowdfunding for unproven stem cell procedures spreads misinformation

          AdobeUsingonlineplatformssuchasGoFundMetosolicitdonationsforhealth-relatedneedscanhelppeopleaccessle

          read more
          Guidelines to prevent youth baseball injuries need more muscle
          Guidelines to prevent youth baseball injuries need more muscle

          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

          read more

          For one rare type of lung cancer, Pfizer pill reduces progression by 81%

          AP/BusinessWireTherearealotofreasonswhyupdateddataonPfizer’sLorbrena,atreatmentfornon-smallcelllungc